Patents
Sitemap › C07 - Organic chemistry › C07D - Heterocyclic compounds › C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
Patents for C07D 413 - Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms (64,687)
12/2008
12/18/2008WO2008152223A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008WO2008152149A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008WO2008152097A1 Cinnamic acid derivatives as modulators of the ep2 receptor
12/18/2008WO2008152094A2 Substituted acetamides as modulators of the ep2 receptor
12/18/2008WO2008152073A2 Piperazine compounds with a herbicidal action
12/18/2008WO2008152014A2 3-hetrocyclylidene-indolinone derivatives as inhibitors of specific cell cycle kinases
12/18/2008WO2008131000A3 7-substituted indole mcl-1 inhibitors
12/18/2008WO2008130616A3 Diaryl morpholines as cb1 modulators
12/18/2008WO2008130320A3 Novel n- (8-heteroaryltetrahydronaphtalene-2yl) or n- (5- heteroarylchromane-3-yl) carboxamide derivatives for the treatment of pain
12/18/2008WO2008130319A3 Novel n-tetrahydronaphtalene or n-chromane carboxamide derivatives for the treatment of pain
12/18/2008WO2008115259A3 Derivatives of benzoxadiazole suitable for the treatment of cell proliferative diseases
12/18/2008WO2008109991A8 Inhibitors of carnitine palmitoyltransferase and treating cancer
12/18/2008WO2008100457A3 Functionally selective alpha2c adrenoreceptor agonists
12/18/2008WO2008081475A3 Novel crystalline forms of zolmitriptan
12/18/2008WO2008076862A3 1-substituted imidazole derivatives and their use as aldosterone synthase inhibitors
12/18/2008WO2008064054A3 Compounds which modulate the cb2 receptor
12/18/2008US20080312438 -(2-Aminopyrid-6-yl)-5-fluoro-N2-[3-(N-methylamino)carbonylmethyleneoxyphenyl]-2,4-pyrimidinediamine; signal transduction cascade inhibitor; Fc receptors for immunoglobulins IgE and IgG antagonist; autoimmune diseases, antiinflammatory agent; rheumatoid arthritis, multiple sclerosis
12/18/2008US20080312436 Colorless Water-Soluble Organic Luminophores and Intermediates Thereof
12/18/2008US20080312301 Substituted N-Benzo[D]Isoxazol-3-Yl-Amine Compounds as Inhibitors of Mglur5, Serotonin (5-Ht) and Noradrenaline Receptors, and Uses Thereof
12/18/2008US20080312299 Imidazole Derivatives as Fructose-1,6-Bisphosphatase Inhibitors and Pharmaceutical Compositions Containing Them
12/18/2008US20080312292 Antipruritics
12/18/2008US20080312291 Heterocyclic Gaba-b Modulators
12/18/2008US20080312285 Substituted Indazoles as Inhibitors of Phosphodiesterase Type-Iv
12/18/2008US20080312248 Pyrimidinyl Aryl Urea Derivatives Being Fgf Inhibitors
12/18/2008US20080312246 Substituted Piperazines as Metabotropic Glutamate Receptor Antagonists
12/18/2008US20080312240 Bicyclic Piperazines as Metabotropic Glutatmate Receptor Antagonists
12/18/2008US20080312234 Novel compounds, isomer thereof, or pharmaceutically acceptable salts thereof as vanilloid receptor antagonist; and pharmaceutical compositions containing the same
12/18/2008US20080312232 N-(3-fluoro-4-(6-(pyrrolidine-1-carboxamido)pyridin-4-yloxy)phenyl)-1-(2-hydroxy-2-methylpropyl)-5-methyl-3-oxo-2-phenyl-2,3-dihydro-1H-pyrazole-4-carboxamide, used for prophylaxis and treatment of hepatocyte growth factor mediated diseases, such as cancer and angiogenesis
12/18/2008US20080312231 N-{2-[2-(4-benzyl-4-hydroxy-piperidin-1-yl)-2-oxo-ethoxy]-ethyl}-N-ethyl-4-methoxy-2,3,6-trimethyl-phenylsulfonamide; condensing the N-carboxyalkyl phenylsulfonamide with the substituted piperidine; bradykinin receptor antagonists; analgesics; antidiabetics; angiogenesis inhibitors; rheumatic diseases
12/18/2008US20080312230 Organic Compounds
12/18/2008US20080312224 Oxaphenanthrene Derivatives
12/18/2008US20080312222 4-Benzyledene-Piperidin Derivatives
12/18/2008US20080312221 Quinoline derivative and quinazoline derivative inhibiting self-phosphorylation of hepatocytus proliferator receptor, and medicinal composition containing the same
12/18/2008US20080312220 Oxadiazole Derivatives with Crth2 Receptor Activity
12/18/2008US20080312219 Biologically active methylene blue derivatives
12/18/2008US20080312213 7-Pyrazolylbenzazepines Having Affinity For D3 Receptor
12/18/2008US20080312207 Compounds
12/18/2008US20080311644 Amino Methylated 2-Pyridinones
12/18/2008US20080311212 Crystalline isoxazole derivative and pharmaceutical preparation thereof
12/18/2008US20080311179 for treating disease or condition chosen from Parkinson's disease, Huntington's chorea, schizophrenia, anxiety, depression, manic depression, psychoses, epilepsy, obsessive compulsive disorders, mood disorders, migraine, Alzheimer's disease, age related cognitive decline, sleep, eating disorders
12/18/2008US20080311076 Morpholinylanilinoquinazoline Derivatives For Use As Antiviral Agents
12/18/2008US20080311075 Hepatitis C Virus Inhibitors
12/18/2008DE60224400T2 Hepatitis c virus polymerase inhibitoren mit heterobicylischer struktur Hepatitis C virus polymerase inhibitors with heterobicylischer structure
12/18/2008CA2694860A1 Polycyclic indazole derivatives and their use as erk inhibitors for the treatment of cancer
12/18/2008CA2693126A1 Novel dicarboxylic acid derivatives as s1p1 receptor agonists
12/18/2008CA2691987A1 Antibacterial agents
12/18/2008CA2690567A1 New compounds
12/18/2008CA2690348A1 Morpholine derivative
12/18/2008CA2689930A1 Gamma secretase modulators
12/18/2008CA2689209A1 Piperazine compounds having herbicidal action
12/18/2008CA2689117A1 5-heteroaryl substituted indazoles as kinase inhibitors
12/18/2008CA2689102A1 3-amino-6-(1-amino-ethyl)-tetrahydropyran derivatives
12/18/2008CA2688343A1 Heteroaryl-substituted urea modulators of fatty acid amide hydrolase
12/18/2008CA2685402A1 Triaminopyrimidine derivatives as inhibitors of cdc25 phosphatase
12/18/2008CA2684671A1 Isoxazoline insecticides
12/17/2008EP2003132A1 Hetero compound
12/17/2008EP2003119A1 Substituted acetamides as modulators of EP2 receptors
12/17/2008EP2003118A1 Cinnamic acid derivatives as modulators of EP2 receptors
12/17/2008EP2002837A1 Biphenyl sulfonamides as dual angiotensin endothelin receptor antagonists
12/17/2008EP2002834A1 Aryl and hetaryl amides as modulators of EP2 receptors
12/17/2008EP2001863A1 2-(cyclic amino)-pyrimidone derivatives as tpk1 inhibitors
12/17/2008EP2001855A1 Benzimidazole derivatives and their use for modulating the gabaa receptor complex
12/17/2008EP2001851A2 Amide derivatives and their application for the treament of g protein related diseases
12/17/2008EP2001849A1 Pyridine and pyrimidine derivatives as mglur2 antagonists
12/17/2008EP2001481A2 Aprepitant polymorph mixtures
12/17/2008EP2001478A1 Cyclohexyl or piperidinyl carboxamide antibiotic derivatives
12/17/2008EP2001474A2 Bicycloheteroaryl compounds as p2x7 modulators and uses thereof
12/17/2008EP2001298A2 Substituted 5-hetaryl-4-aminopyrimidines
12/17/2008EP1809607B1 Sulfonyl benzimidazole derivatives
12/17/2008EP1753736B1 Inhibitors of 11-beta-hydroxy steroid dehydrogenase type 1
12/17/2008EP1443046B1 Novel 4-(2furoyl)aminopiperidines, intermediates in synthesizing the same, process for producing the same and medicinal use of the same
12/17/2008EP1425001B1 Phenethanolamine derivatives for treatment of respiratory diseases
12/17/2008EP1417176B1 Substituted anthranilamides for controlling invertebrate pests
12/17/2008CN101326167A Pyridiazinone derivatives for tumour treatment
12/17/2008CN101323592A Substituted phenyl pyrazole ether compounds and application thereof
12/17/2008CN101323589A Preparation of novel compound and montelukast sodium
12/17/2008CN100443481C Imidazolyl-cyclic acetals
12/17/2008CN100443477C Substituted benzoxazoles and analogues as estrogenic agents
12/17/2008CN100443474C New pyridazin-3(2h)-one derivatives
12/17/2008CN100443469C 病毒聚合酶抑制剂 Viral polymerase inhibitors
12/16/2008US7465811 [3-[[[[2,3-dihydro-1-[[3'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]sulfonyl]-1H-indol-2-yl]carbonyl]amino]methyl]phenoxy]acetic acid methyl ester; retinoic acid, farnesoid X, peroxisome proliferator-activated receptors modulator; antiinflammatory, antidiabetic agent, atherosclerosis, Alzheimer's disease
12/16/2008US7465806 N-(1-alkyl-4-piperidinyl)-2-pyrrolecarboxamides, e.g., 1-[5-(5-Chloro-thiophen-2-yl)-isoxazol-3-ylmethyl]-1H-pyrrole-2-carboxylic acid (1-isopropyl-piperidin-4-yl)-amide; treating vascular restenosis following angioplasty
12/16/2008US7465750 Use of GAL3 antagonist for treatment of depression and/or anxiety and compounds useful in such methods
12/16/2008US7465748 Amide derivative
12/16/2008US7465746 Fluorinated 2,4-diaryl-2,5-dihydropyrrole inhibitors of the mitotic kinesin KSP
12/16/2008US7465745 Cathepsin S inhibitors
12/16/2008US7465736 e.g. (2-chloropyrimidin-4-yl)-(4-ethyl-3H-thiazol-2ylidene)-acetonitrile,[4-(4-chlorophenyl)-1,3-thiazol-2(3H)-ylidene](2-chloropyrimidin-4-yl)acetonitrile; Jun N-terminal kinase and Glycogen Synthase Kinase 3 inhibitor; antidiabetic, antiinflammatory, anticarcinogenic agent; neurodegenerative diseases
12/16/2008US7465732 (2S,4S)-4-(piperazin-1-yl)pyrrolidine-2-methanone derivatives
12/16/2008US7465728 Derivatives of 4-(imidazol-5-yl)-2-(4-sulfoanilino)pyrimidine with CDK inhibitory activity
12/16/2008US7465726 Substituted pyrrolo[2.3-B]pyridines
12/16/2008US7465725 e.g. N-{2-[3-(3,4-dimethoxy-phenyl)-propyl]-6-morpholin-4-yl-pyrimidin-4-yl}-N'-(1H-indol-3-ylmethylene)-hydrazine; interleukin-12 antagonist; antiinflammatory, antidiabetic agent; rheumatoid arthritis, sepsis, Crohn's disease, multiple sclerosis, psoriasis, or insulin-dependent diabetes mellitus
12/16/2008US7465718 Ansamycins having improved pharmacological and biological properties
12/16/2008CA2398887C 2,4,di(hetero-)arylamino(-oxy)-5-substituted pyrimidines as antineoplastic agents
12/11/2008WO2008151303A1 Long wavelength fluorogenic intercellular ion indicators
12/11/2008WO2008150486A2 2-acylaminopropoanol-type glucosylceramide synthase inhibitors
12/11/2008WO2008150393A1 3-cyano-4-triazolyl phenylisoxazoline invertebrate pest control agents
12/11/2008WO2008150233A1 Oxadiazole derivatives and their use as metabotropic glutamate receptor potentiators - 842
12/11/2008WO2008150232A1 Metabotropic glutamate receptor oxadiazole ligands and their use as potentiators - 841
12/11/2008WO2008150231A1 New heterocyclic compounds for treatment of respiratory, airway or inflammatory disorders
12/11/2008WO2008149965A1 Pyridone compound
1 ... 221 222 223 224 225 226 227 228 229 230 231 232 233 234 235 236 237 238 239 240 241 ... 647